Compare DOLE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOLE | ATRC |
|---|---|---|
| Founded | 1851 | 2000 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2021 | 2005 |
| Metric | DOLE | ATRC |
|---|---|---|
| Price | $14.57 | $36.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $52.22 |
| AVG Volume (30 Days) | ★ 697.6K | 422.0K |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $8,974,210,000.00 | $518,304,999.00 |
| Revenue This Year | $9.28 | $16.90 |
| Revenue Next Year | $1.84 | $12.25 |
| P/E Ratio | $97.15 | ★ N/A |
| Revenue Growth | 7.09 | ★ 15.80 |
| 52 Week Low | $12.20 | $28.29 |
| 52 Week High | $15.73 | $43.18 |
| Indicator | DOLE | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 37.68 |
| Support Level | $13.83 | $38.68 |
| Resistance Level | $14.74 | $43.18 |
| Average True Range (ATR) | 0.25 | 1.48 |
| MACD | -0.08 | -0.53 |
| Stochastic Oscillator | 52.33 | 0.00 |
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.